Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 3 1

Status

Completed 4Terminated 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5Expanded_access 1

Sponsor

Cancer Type

CNS 5Sarcoma 3

Conditions

Gliosarcoma 3Glioblastoma 3Brain Neoplasms 3Neoplasms 2Glioma 2Recurrence 1Brain Stem Neoplasms 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × rindopepimut × Clear all
NCT01058850 2021-09-27

Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas

Stanford University

Phase 1 Terminated
3 enrolled
CNS

Brain Neoplasms, Brain Stem Neoplasms

NCT01498328 2020-02-17

ReACT

Celldex Therapeutics

Phase 2 Completed
127 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Neoplasms, Recurrence, Gliosarcoma

NCT00458601 2018-01-16

ACT III

Celldex Therapeutics

Phase 2 Completed
82 enrolled
CNS

Glioma

NCT01480479 2018-01-16

ACT IV

Celldex Therapeutics

Phase 3 Completed
745 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Neoplasms, Gliosarcoma

NCT00626015 2016-01-21

ZAP IT

Duke University

Phase 1 Completed
16 enrolled
CNSSarcoma

Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡